239 related articles for article (PubMed ID: 22654117)
1. Polydom/SVEP1 is a ligand for integrin α9β1.
Sato-Nishiuchi R; Nakano I; Ozawa A; Sato Y; Takeichi M; Kiyozumi D; Yamazaki K; Yasunaga T; Futaki S; Sekiguchi K
J Biol Chem; 2012 Jul; 287(30):25615-30. PubMed ID: 22654117
[TBL] [Abstract][Full Text] [Related]
2. The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.
Morris GE; Denniff MJ; Karamanavi E; Andrews SA; Kostogrys RB; Bountziouka V; Ghaderi-Najafabadi M; Shamkhi N; McConnell G; Kaiser MA; Carleton L; Schofield C; Kessler T; Rainbow RD; Samani NJ; Webb TR
Br J Pharmacol; 2022 Nov; 179(21):4958-4973. PubMed ID: 35802072
[TBL] [Abstract][Full Text] [Related]
3. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin.
Marcinkiewicz C; Taooka Y; Yokosaki Y; Calvete JJ; Marcinkiewicz MM; Lobb RR; Niewiarowski S; Sheppard D
J Biol Chem; 2000 Oct; 275(41):31930-7. PubMed ID: 10926928
[TBL] [Abstract][Full Text] [Related]
5. Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site.
Nishimichi N; Higashikawa F; Kinoh HH; Tateishi Y; Matsuda H; Yokosaki Y
J Biol Chem; 2009 May; 284(22):14769-76. PubMed ID: 19346516
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
Pepinsky RB; Mumford RA; Chen LL; Leone D; Amo SE; Riper GV; Whitty A; Dolinski B; Lobb RR; Dean DC; Chang LL; Raab CE; Si Q; Hagmann WK; Lingham RB
Biochemistry; 2002 Jun; 41(22):7125-41. PubMed ID: 12033947
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the recognition of nephronectin by integrin alpha8beta1.
Sato Y; Uemura T; Morimitsu K; Sato-Nishiuchi R; Manabe R; Takagi J; Yamada M; Sekiguchi K
J Biol Chem; 2009 May; 284(21):14524-36. PubMed ID: 19342381
[TBL] [Abstract][Full Text] [Related]
8. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.
Vlahakis NE; Young BA; Atakilit A; Sheppard D
J Biol Chem; 2005 Feb; 280(6):4544-52. PubMed ID: 15590642
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins.
Staniszewska I; Sariyer IK; Lecht S; Brown MC; Walsh EM; Tuszynski GP; Safak M; Lazarovici P; Marcinkiewicz C
J Cell Sci; 2008 Feb; 121(Pt 4):504-13. PubMed ID: 18230652
[TBL] [Abstract][Full Text] [Related]
10. Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.
Morooka N; Futaki S; Sato-Nishiuchi R; Nishino M; Totani Y; Shimono C; Nakano I; Nakajima H; Mochizuki N; Sekiguchi K
Circ Res; 2017 Apr; 120(8):1276-1288. PubMed ID: 28179430
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-C: Its functions as an integrin ligand.
Tucker RP; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 Aug; 65():165-8. PubMed ID: 26055518
[TBL] [Abstract][Full Text] [Related]
12. SVEP1 influences monocyte to macrophage differentiation via integrin α4β1/α9β1 and Rho/Rac signalling.
Andrews SL; Ghaderi-Najafabadi M; Gong P; Shamkhi N; Carleton L; Schofield C; Kessler T; Samani NJ; Webb TR; Morris GE
Biochim Biophys Acta Mol Cell Res; 2023 Aug; 1870(6):119479. PubMed ID: 37100352
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of the integrin alpha9beta1 in bovine aortic valve interstitial cells.
Wiester LM; Giachelli CM
J Heart Valve Dis; 2003 Sep; 12(5):605-16. PubMed ID: 14565714
[TBL] [Abstract][Full Text] [Related]
14. α9β1 integrin acts as a critical intrinsic regulator of human rheumatoid arthritis.
Asano T; Iwasaki N; Kon S; Kanayama M; Morimoto J; Minami A; Uede T
Rheumatology (Oxford); 2014 Mar; 53(3):415-24. PubMed ID: 24241034
[TBL] [Abstract][Full Text] [Related]
15. Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C.
Yokosaki Y; Matsuura N; Higashiyama S; Murakami I; Obara M; Yamakido M; Shigeto N; Chen J; Sheppard D
J Biol Chem; 1998 May; 273(19):11423-8. PubMed ID: 9565552
[TBL] [Abstract][Full Text] [Related]
16. Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit.
Kon S; Atakilit A; Sheppard D
Exp Cell Res; 2011 Jul; 317(12):1774-84. PubMed ID: 21515257
[TBL] [Abstract][Full Text] [Related]
17. Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts.
Ota D; Kanayama M; Matsui Y; Ito K; Maeda N; Kutomi G; Hirata K; Torigoe T; Sato N; Takaoka A; Chambers AF; Morimoto J; Uede T
J Mol Med (Berl); 2014 Dec; 92(12):1271-81. PubMed ID: 25099519
[TBL] [Abstract][Full Text] [Related]
18. Hierarchy of ADAM12 binding to integrins in tumor cells.
Thodeti CK; Fröhlich C; Nielsen CK; Holck P; Sundberg C; Kveiborg M; Mahalingam Y; Albrechtsen R; Couchman JR; Wewer UM
Exp Cell Res; 2005 Oct; 309(2):438-50. PubMed ID: 16061220
[TBL] [Abstract][Full Text] [Related]
19. Suppression of integrin α3β1 by α9β1 in the epidermis controls the paracrine resolution of wound angiogenesis.
Longmate WM; Lyons SP; Chittur SV; Pumiglia KM; Van De Water L; DiPersio CM
J Cell Biol; 2017 May; 216(5):1473-1488. PubMed ID: 28416479
[TBL] [Abstract][Full Text] [Related]
20. The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1.
Taooka Y; Chen J; Yednock T; Sheppard D
J Cell Biol; 1999 Apr; 145(2):413-20. PubMed ID: 10209034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
